1. Home
  2. UTHR vs PAG Comparison

UTHR vs PAG Comparison

Compare UTHR & PAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • PAG
  • Stock Information
  • Founded
  • UTHR 1996
  • PAG 1990
  • Country
  • UTHR United States
  • PAG United States
  • Employees
  • UTHR N/A
  • PAG N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • PAG Retail-Auto Dealers and Gas Stations
  • Sector
  • UTHR Health Care
  • PAG Consumer Discretionary
  • Exchange
  • UTHR Nasdaq
  • PAG Nasdaq
  • Market Cap
  • UTHR 13.8B
  • PAG 11.1B
  • IPO Year
  • UTHR 1999
  • PAG 1996
  • Fundamental
  • Price
  • UTHR $303.96
  • PAG $184.38
  • Analyst Decision
  • UTHR Buy
  • PAG Buy
  • Analyst Count
  • UTHR 13
  • PAG 6
  • Target Price
  • UTHR $382.00
  • PAG $179.17
  • AVG Volume (30 Days)
  • UTHR 694.7K
  • PAG 210.2K
  • Earning Date
  • UTHR 10-29-2025
  • PAG 10-28-2025
  • Dividend Yield
  • UTHR N/A
  • PAG 2.86%
  • EPS Growth
  • UTHR 17.94
  • PAG 5.84
  • EPS
  • UTHR 25.63
  • PAG 14.36
  • Revenue
  • UTHR $3,077,800,000.00
  • PAG $30,577,500,000.00
  • Revenue This Year
  • UTHR $13.89
  • PAG $2.11
  • Revenue Next Year
  • UTHR $5.68
  • PAG $3.85
  • P/E Ratio
  • UTHR $11.89
  • PAG $12.84
  • Revenue Growth
  • UTHR 17.62
  • PAG 2.39
  • 52 Week Low
  • UTHR $266.98
  • PAG $134.05
  • 52 Week High
  • UTHR $417.82
  • PAG $189.51
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 52.97
  • PAG 56.63
  • Support Level
  • UTHR $302.19
  • PAG $180.23
  • Resistance Level
  • UTHR $312.44
  • PAG $189.51
  • Average True Range (ATR)
  • UTHR 6.59
  • PAG 3.46
  • MACD
  • UTHR -0.48
  • PAG 0.32
  • Stochastic Oscillator
  • UTHR 60.65
  • PAG 62.52

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About PAG Penske Automotive Group Inc.

Penske Automotive Group operates in 19 US states and overseas. It has over 150 US and Puerto Rico light-vehicle stores as well as 210 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Germany, Italy, and Japan. The company is the third-largest US publicly traded dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 45 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns 16 used-vehicle stores, mostly in the US and UK under the CarShop (US) and Sytner Select (UK) brands. Penske is based in Bloomfield Hills, Michigan.

Share on Social Networks: